The effect of natural turpentine Kurdica on Helicobacter pylori
Phase 2
- Conditions
- H. pylori infection of the stomach.Other and unspecified infectious diseases
- Registration Number
- IRCT2016042527599N1
- Lead Sponsor
- Vice chancellor for Research Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion criteria
Gastrointestinal clinic patients 20 to 40 years old; UBT positive symptoms of indigestion; avoiding the use of antibiotics
Exclusion criteria
Pregnancy and lactation; the development of pharmaceutical agents stopped the study; travel or unwillingness to continue treatment; lack of medication; taking the wrong medication
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function changes. Timepoint: 2 days before and 30 days after the intervention. Method of measurement: According to the DOB.
- Secondary Outcome Measures
Name Time Method Headache - abdominal pain - diarrhea - nausea. Timepoint: During the intervention. Method of measurement: Qualitative.